Baxter Ramps Up Production, FDA Extends IV Drug Expiration Dates

Baxter International will likely resume standard production on its highest-throughput manufacturing line for IV solutions, the company said in a statement Monday (Oct. 28), after its facility in North Carolina was flooded during Hurricane Helene, leading to shortages of several IV drug products. FDA is also allowing shelf-life extensions for several of Baxter’s IV drug products, and the company says it may soon be able to provide drugs to more peritoneal dialysis patients after limiting new patients to children only...